Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Li

Showing results (141-150 of 162) with videos related to

Pageof 17
Sort By:
ERJ Open Research|January 19, 2023
Nasal epithelial cell culture fluorescence recovery after photobleaching predicts cystic fibrosis therapeutic responseTimothy E Corcoran, Carol A Bertrand, Michael M Myerburg, et al.
Fluids and Barriers of the CNS|January 8, 2026
Neurovascular and metabolic dysfunction with cell type-specific transcriptomic changes in presymptomatic 5XFAD miceMinmin Yao, Na Sun, Raleigh Linville, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 26, 2025
EAAT3 modulation: A potential novel avenue towards remyelination in multiple sclerosisLieve van Veggel, Melissa Schepers, Assia Tiane, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 1, 2004
Potential utility of BimS as a novel apoptotic therapeutic moleculeKenneth W Yip, Anna Li, Jian-Hua Li, et al.
Mbio|December 14, 2021
Combining Ivacaftor and Intensive Antibiotics Achieves Limited Clearance of Cystic Fibrosis InfectionsSamantha L Durfey, Sudhakar Pipavath, Anna Li, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 25, 2021
Repeated Administration of 2-Hydroxypropyl-β-Cyclodextrin (HPβCD) Attenuates the Chronic Inflammatory Response to Experimental StrokeDanielle A Becktel, Jacob C Zbesko, Jennifer B Frye, et al.
Nature Communications|January 13, 2026
Osimertinib with or without savolitinib as first-line treatment for MET-aberrant, EGFR-mutant NSCLC: randomized phase 2 trial (FLOWERS)Anna Li, Wei-Neng Feng, Juan Li, et al.
Cancer Research|May 15, 2024
HiChIP-Based Epigenomic Footprinting Identifies a Promoter Variant of UXS1 That Confers Genetic Susceptibility to Gastroesophageal CancerAnsley Gnanapragasam, Eftyhios Kirbizakis, Anna Li, et al.
ACS Chemical Neuroscience|March 13, 2024
Still in Search for an EAAT Activator: GT949 Does Not Activate EAAT2, nor EAAT3 in Impedance and Radioligand Uptake AssaysLieve van Veggel, Tamara A M Mocking, Hubert J Sijben, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2025
Bispecific BAFF-R/BCMA CAR T cells control growth of heterogeneous plasma cells in multiple myelomaAgnese Fiori, Karin Zimmermann, Anna Li, et al.
Pageof 17

Showing results (141-150 of 162) with videos related to

Sort By:
Pageof 17
ERJ Open Research|January 19, 2023
Nasal epithelial cell culture fluorescence recovery after photobleaching predicts cystic fibrosis therapeutic responseTimothy E Corcoran, Carol A Bertrand, Michael M Myerburg, et al.
Fluids and Barriers of the CNS|January 8, 2026
Neurovascular and metabolic dysfunction with cell type-specific transcriptomic changes in presymptomatic 5XFAD miceMinmin Yao, Na Sun, Raleigh Linville, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 26, 2025
EAAT3 modulation: A potential novel avenue towards remyelination in multiple sclerosisLieve van Veggel, Melissa Schepers, Assia Tiane, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 1, 2004
Potential utility of BimS as a novel apoptotic therapeutic moleculeKenneth W Yip, Anna Li, Jian-Hua Li, et al.
Mbio|December 14, 2021
Combining Ivacaftor and Intensive Antibiotics Achieves Limited Clearance of Cystic Fibrosis InfectionsSamantha L Durfey, Sudhakar Pipavath, Anna Li, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 25, 2021
Repeated Administration of 2-Hydroxypropyl-β-Cyclodextrin (HPβCD) Attenuates the Chronic Inflammatory Response to Experimental StrokeDanielle A Becktel, Jacob C Zbesko, Jennifer B Frye, et al.
Nature Communications|January 13, 2026
Osimertinib with or without savolitinib as first-line treatment for MET-aberrant, EGFR-mutant NSCLC: randomized phase 2 trial (FLOWERS)Anna Li, Wei-Neng Feng, Juan Li, et al.
Cancer Research|May 15, 2024
HiChIP-Based Epigenomic Footprinting Identifies a Promoter Variant of UXS1 That Confers Genetic Susceptibility to Gastroesophageal CancerAnsley Gnanapragasam, Eftyhios Kirbizakis, Anna Li, et al.
ACS Chemical Neuroscience|March 13, 2024
Still in Search for an EAAT Activator: GT949 Does Not Activate EAAT2, nor EAAT3 in Impedance and Radioligand Uptake AssaysLieve van Veggel, Tamara A M Mocking, Hubert J Sijben, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2025
Bispecific BAFF-R/BCMA CAR T cells control growth of heterogeneous plasma cells in multiple myelomaAgnese Fiori, Karin Zimmermann, Anna Li, et al.
Pageof 17